FDA Import Refusal AEK-7364558-0/12/1 — INCEPTA PHARMACEUTICALS
The FDA refused shipment AEK-7364558-0/12/1 from INCEPTA PHARMACEUTICALS (Bangladesh) on September 24, 2025. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- September 24, 2025
- Country
- Bangladesh
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 75